Neuronetics (STIM) News Today $3.99 0.00 (0.00%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$4.13 +0.14 (+3.53%) As of 05/23/2025 06:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock STIM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Neuronetics, Inc. (NASDAQ:STIM) EVP Sells $826,074.20 in StockMay 15, 2025 | insidertrades.comBalyasny Asset Management L.P. Grows Position in Neuronetics, Inc. (NASDAQ:STIM)Balyasny Asset Management L.P. grew its position in shares of Neuronetics, Inc. (NASDAQ:STIM - Free Report) by 29.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,481,771 shares of the company's stock after acquiriMay 15, 2025 | marketbeat.comNeuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness MonthMay 14, 2025 | tmcnet.comQ2 EPS Estimates for Neuronetics Reduced by William BlairNeuronetics, Inc. (NASDAQ:STIM - Free Report) - Analysts at William Blair decreased their Q2 2025 earnings per share (EPS) estimates for Neuronetics in a research note issued on Tuesday, May 6th. William Blair analyst M. Andrew now forecasts that the company will earn ($0.09) per share for the quMay 11, 2025 | marketbeat.comNeuronetics Announces Inducement Awards for New Team MembersMay 10, 2025 | msn.comNeuronetics, Inc. (NASDAQ:STIM) Released Earnings Last Week And Analysts Lifted Their Price Target To US$6.83May 9, 2025 | finance.yahoo.comNeuronetics (NASDAQ:STIM) Posts Quarterly Earnings Results, Misses Expectations By $0.08 EPSNeuronetics (NASDAQ:STIM - Get Free Report) released its earnings results on Tuesday. The company reported ($0.21) earnings per share for the quarter, missing analysts' consensus estimates of ($0.13) by ($0.08). Neuronetics had a negative net margin of 50.09% and a negative return on equity of 141.24%.May 8, 2025 | marketbeat.comRenaissance Technologies LLC Has $255,000 Position in Neuronetics, Inc. (NASDAQ:STIM)Renaissance Technologies LLC cut its holdings in Neuronetics, Inc. (NASDAQ:STIM - Free Report) by 72.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 158,600 shares of the company's stock after selling 423,200 shares during the period. RenaissaMay 8, 2025 | marketbeat.comEarnings call transcript: Neuronetics Q1 2025 misses EPS, stock drops 22%May 7, 2025 | investing.comNeuronetics Reports 84% Revenue Growth in Q1 2025 Driven by Greenbrook AcquisitionMay 7, 2025 | nasdaq.comNeuronetics Reports 84% Revenue Growth in Q1 2025 Driven by Greenbrook AcquisitionMay 7, 2025 | nasdaq.comNeuronetics Inc (STIM) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Margin ChallengesMay 7, 2025 | finance.yahoo.comNeuronetics, Inc. (STIM) Q1 2025 Earnings Call TranscriptMay 6, 2025 | seekingalpha.comNeuronetics Reports First Quarter 2025 Financial and Operating ResultsMay 6, 2025 | globenewswire.comNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)May 5, 2025 | globenewswire.comNeuronetics (STIM) to Release Quarterly Earnings on TuesdayNeuronetics (NASDAQ:STIM) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-neuronetics-inc-stock/)May 1, 2025 | marketbeat.comWhy Neuronetics, Inc. (STIM) is Surging in 2025April 30, 2025 | msn.comNeuronetics to Announce Q1 2025 Results and Host Live Conference Call on May 6April 24, 2025 | msn.comNeuronetics, Inc. (NASDAQ:STIM) Sees Significant Growth in Short InterestNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) was the recipient of a large increase in short interest in March. As of March 31st, there was short interest totalling 3,340,000 shares, an increase of 20.1% from the March 15th total of 2,780,000 shares. Approximately 12.2% of the company's stock are short sold. Based on an average daily volume of 1,630,000 shares, the short-interest ratio is presently 2.0 days.April 23, 2025 | marketbeat.comNeuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference CallApril 22, 2025 | tmcnet.comNeuronetics Announces Expanded Coverage for NeuroStar TMS to Treat Adolescent DepressionApril 2, 2025 | msn.comNeuronetics announces Evernorth Health expanded its coverage of NeuroStar TMSMarch 31, 2025 | markets.businessinsider.comNeuronetics, Inc. (NASDAQ:STIM) Short Interest Up 39.7% in MarchNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 2,780,000 shares, a growth of 39.7% from the February 28th total of 1,990,000 shares. Approximately 10.2% of the shares of the company are sold short. Based on an average daily volume of 1,440,000 shares, the days-to-cover ratio is currently 1.9 days.March 31, 2025 | marketbeat.comEvernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with DepressionMarch 31, 2025 | globenewswire.comNeuronetics: Explosive Growth Poised To Soar On FDA BreakthroughsMarch 30, 2025 | seekingalpha.comNeuronetics Revises Financial Results for Q4 and Full Year 2024March 29, 2025 | msn.comWilliam Blair Keeps Their Hold Rating on Neuronetics (STIM)March 28, 2025 | markets.businessinsider.comNeuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating ResultsMarch 27, 2025 | globenewswire.comThis Penny Stock Is Up 170% in 2025 and Analysts Think It Can Rally Further From HereMarch 25, 2025 | msn.comWhile private equity firms own 38% of Neuronetics, Inc. (NASDAQ:STIM), retail investors are its largest shareholders with 43% ownershipMarch 23, 2025 | finance.yahoo.comNeuronetics, Inc. (NASDAQ:STIM) Sees Significant Increase in Short InterestNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) was the recipient of a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 1,990,000 shares, an increase of 24.4% from the February 13th total of 1,600,000 shares. Based on an average trading volume of 1,330,000 shares, the short-interest ratio is presently 1.5 days. Currently, 7.3% of the shares of the company are sold short.March 18, 2025 | marketbeat.comWilliam Blair Forecasts Increased Earnings for NeuroneticsNeuronetics, Inc. (NASDAQ:STIM - Free Report) - Equities research analysts at William Blair boosted their Q1 2025 EPS estimates for Neuronetics in a research report issued to clients and investors on Wednesday, March 5th. William Blair analyst M. Andrew now forecasts that the company will post eaMarch 8, 2025 | marketbeat.comNeuronetics (NASDAQ:STIM) Given New $8.00 Price Target at Canaccord Genuity GroupCanaccord Genuity Group raised their target price on Neuronetics from $5.00 to $8.00 and gave the company a "buy" rating in a report on Wednesday.March 6, 2025 | marketbeat.comNeuronetics price target raised to $8 from $5 at CanaccordMarch 5, 2025 | markets.businessinsider.comNeuronetics, Inc. (NASDAQ:STIM) Q4 2024 Earnings Call TranscriptMarch 5, 2025 | msn.comNeuronetics price target raised to $7 from $3 at Citizens JMPMarch 5, 2025 | markets.businessinsider.comNeuronetics Shares Rise in Premarket on Rosy Growth OutlookMarch 4, 2025 | marketwatch.comNeuronetics reports Q4 EPS (33c), consensus (24c)March 4, 2025 | markets.businessinsider.comNeuronetics, Inc. (STIM) Q4 2024 Earnings Call TranscriptMarch 4, 2025 | seekingalpha.comNeuronetics (NASDAQ:STIM) Issues Earnings Results, Misses Expectations By $0.07 EPSNeuronetics (NASDAQ:STIM - Get Free Report) announced its earnings results on Tuesday. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by ($0.07). Neuronetics had a negative net margin of 50.09% and a negative return on equity of 141.24%.March 4, 2025 | marketbeat.comNeuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating ResultsMarch 4, 2025 | globenewswire.comNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)March 3, 2025 | globenewswire.comNeuronetics (STIM) Projected to Post Quarterly Earnings on TuesdayNeuronetics (NASDAQ:STIM) will be releasing earnings before the market opens on Tuesday, March 4. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=669079)February 25, 2025 | marketbeat.comNeuronetics, Inc. (STIM): Among the Hot Penny Stocks to Buy NowFebruary 23, 2025 | msn.comNeuronetics to Announce Q4 2024 Results on March 4, 2025February 22, 2025 | msn.comNeuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference CallFebruary 21, 2025 | markets.businessinsider.comInsider Selling: Neuronetics, Inc. (NASDAQ:STIM) CFO Sells 17,307 Shares of StockNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) CFO Stephen Furlong sold 17,307 shares of the firm's stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $4.11, for a total value of $71,131.77. Following the completion of the transaction, the chief financial officer now owns 454,420 shares in the company, valued at approximately $1,867,666.20. This trade represents a 3.67 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.February 19, 2025 | marketbeat.comStephen Furlong Sells 17,307 Shares of Neuronetics, Inc. (NASDAQ:STIM) StockFebruary 19, 2025 | insidertrades.comInsider Selling: Neuronetics, Inc. (NASDAQ:STIM) CFO Sells 10,845 Shares of StockNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) CFO Stephen Furlong sold 10,845 shares of the stock in a transaction on Wednesday, February 12th. The shares were sold at an average price of $3.83, for a total transaction of $41,536.35. Following the transaction, the chief financial officer now owns 471,727 shares of the company's stock, valued at $1,806,714.41. This trade represents a 2.25 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.February 15, 2025 | marketbeat.comNeuronetics, Inc. (NASDAQ:STIM) EVP Sells $46,630.25 in StockNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) EVP William Andrew Macan sold 12,175 shares of the company's stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $3.83, for a total value of $46,630.25. Following the sale, the executive vice president now owns 388,647 shares of the company's stock, valued at $1,488,518.01. The trade was a 3.04 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.February 15, 2025 | marketbeat.com Get Neuronetics News Delivered to You Automatically Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter. Email Address STIM Media Mentions By Week STIM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. STIM News Sentiment▼0.000.75▲Average Medical News Sentiment STIM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. STIM Articles This Week▼02▲STIM Articles Average Week Get Neuronetics News Delivered to You Automatically Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FNA News Today BLFS News Today ESTA News Today MDXG News Today INMD News Today SIBN News Today IRMD News Today EMBC News Today RXST News Today BBNX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:STIM) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuronetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuronetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
